KIRSTEN SCHMITT: Open Payments
NPI 1528121811 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,758 in 131 payments from 20 companies in 2025. Trend: 2023 $2,319 · 2024 $2,157 · 2025 $2,758
Food & beverage: $2,758
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $537 |
| GlaxoSmithKline, LLC. | 22 | $359 |
| Novartis Pharmaceuticals Corporation | 11 | $296 |
| Amgen Inc. | 11 | $220 |
| GENZYME CORPORATION | 8 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $177 |
| CSL Behring | 7 | $160 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $127 |
| Genentech USA, Inc. | 4 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, AIRSUPRA, Xolair, NEFFY, Rhapsido, VTAMA.
Industry payments across MI — which companies pay providers there.
